Investments

Co-Investment

GBA Group

Germany

28 April 2021

Healthcare & life science

Healthcare & life science

GBA Group is a leading independent provider of highest-quality bio-analytical laboratory services for food, sustainability & environment, medical device, and pharmaceutical testing. The group focuses on tailor-made solutions to meet its clients’ needs, backed by its strong scientific expertise, very comprehensive service portfolio as well as continuous dialogue with its customers. Headquartered in Hamburg, GBA employs well over 2,500 employees and operates more than 65 labs across central Europe, the US and Asia.

Deal team

Gunnar Chrestin

Philipp Lattermann

Christian Koch

https://www.gba-group.com/

https://twitter.com/GBAGroupPharma

https://de.linkedin.com/company/gbagroup

The Ardian team brought a deep sector knowledge, which I think allowed them not only to do a terrific job in that due diligence period, but also meant they could work very efficiently within our deal time frame.

Doug Brody KKR Capital Market

Ardian and Arsenal both want our investments to benefit society and by working together in this case we’ve reduced the time it takes to set up a clinical trial by many months, which means new drugs come to market as quickly and safely as possible.

Steve McLean Partner of Arsenal Capital

During the due diligence phase, we identified Ardian as a future shareholder capable of making a significant contribution to Emera's development. As soon as the transaction closed, we were able to define and launch value-creating initiatives with Naxicap and Ardian, particularly in terms of group structuring, external growth, digital transformation and real estate strategy, in France but also in Spain and other European countries.

Eric Baugas CEO of EMERA

Co-Investment

Expertise
Co-Investment

Team

Investments

GBA Group

Deal team